About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: April 23, 2007
    To better understand disability in the United States, the Centers for Disease Control, the Department of Education, and the National Institutes of Health (NIH) asked the Institute of Medicine (IOM) to assess the current situation and provide recommendations for improvement, which culminated in the report The Future of Disability in America.
  • Released: April 12, 2007
    All drugs undergo extensive safety and efficacy studies before being released; however, these studies can fail to identify potential adverse reactions that are rare or develop over a long period of use. As a result, serious adverse reactions may not be fully appreciated until a drug has been on the market for many years. In November 2005, the Forum on Drug Discovery, Development, and Translation addressed this critical concern by convening a workshop to explore issues associated with the reporting of adverse drug events, and to consider how the roles of clinicians and patients in reporting such events can be enhanced.
  • Released: March 30, 2007
    In 2003 Congress passed the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which established a five-year, $15 billion initiative to help countries around the world respond to their AIDS epidemics. The initiative is generally referred to by the title of the five-year strategy required by the act—PEPFAR, or the President’s Emergency Plan for AIDS Relief.
  • Released: March 30, 2007
    The Roundtable serves as a neutral venue for cooperative work among key stakeholders on several dimensions: to help transform the availability and use of the best evidence for the collaborative health care choices of each patient and provider; to drive the process of discovery as a natural outgrowth of patient care; and, ultimately, to ensure innovation, quality, safety, and value in health care.
  • Released: March 29, 2007
    An IOM committee was convened to review biomarker research, development, and implementation. The committee was asked to examine questions regarding the discovery, development, adoption, and use of biomarkers for cancer screening, diagnosis, and treatment, with the goal of identifying obstacles to progress that could potentially be overcome through policy changes.
  • Released: March 22, 2007
    The IOM's National Cancer Policy Forum sponsored a public workshop addressing several issues related to cancer and aging; including cancer rehabilitation, increased prevalence of cancer survivors, end of life care, the role of nurses, and Medicare costs in geriatric oncology.
  • Released: March 14, 2007
    Given the unprecedented environment in the United States in which two-thirds of the adult population meets the criteria for being overweight or obese, the implications for women in the reproductive age period are unique in the history of the country. In May 2006, at the request of the Health Resources and Services Administration’s Maternal and Child Health Bureau in the U.S. Department of Health and Human Services, the National Research Council and the Institute of Medicine convened a workshop to examine emerging research findings related to the complex relationship of the biological, behavioral, psychological, and social interactions that affect maternal and pregnancy weight on maternal and child health outcomes.
  • Released: February 28, 2007
    At the request of the National Aeronautics and Space Administration (NASA), the Institute of Medicine (IOM) established a committee and issued the report Review of NASA's Space Flight Health Standards-Setting Process: Letter Report. The committee was charged with examining the process by which NASA establishes space flight health standards for human performance. It assured the transparency of the current process, as well as considering its validity and integrity, particularly related to ensuring worker safety and integrating stakeholder input.
  • Released: February 21, 2007
    Global regulatory standards will always be a major driver in the field of environmental health, but there is a growing understanding of the value of voluntary standards to fill in gaps or to work in concert with formal regulations. The Roundtable on Environmental Health Sciences, Research, and Medicine held a workshop to examine some of the issues surrounding the impact international regulations and corporate social responsibility (CSR) has on environmental health.
  • Released: February 13, 2007
    Over the past decade, significant improvements have occurred in the rate of teen motor vehicle crashes, but teen drivers and passengers remain at substantial risk. The workshop and subsequent summary report, Preventing Teen Motor Crashes: Contributions from the Behavioral and Social Sciences, sponsored by the NIH Office of Behavioral and Social Sciences Research, the CDC Center for Injury Prevention and Control, and State Farm Insurance Companies, was organized to explore how knowledge from the behavioral and social sciences could contribute to the development of new prevention strategies to reduce the burden of injury and death from teen motor vehicle crashes.
Buy Fenilver online

Buy GHRP-2 online